Rongtao Wang
State Key Laboratory Of Discovery And Utilization Of Functional Components In Traditional Chinese Medicine
Guiyang, 550014, China
Guiyang, 550014, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Corrigendum to "Orthosteric-allosteric dual inhibitors of PI5P4Kγ with potent antitumor activity in non-small cell lung cancer" [J. Adv. Res. 84 (2026) 1105-1126].
Journal: Journal of advanced research
Published: August 17, 2026
Development of novel nanoliposomes co-loaded with ROR1 inhibitor and Ce6 for the treatment of EGFR-TKIs resistant NSCLC by synergistic targeted inhibitor therapy and photodynamic therapy.
Journal: Journal of photochemistry and photobiology. B, Biology
Published: March 31, 2026
Anti-NSCLC efficacy of a novel ROR1/PI3Kα/BRD4 multi-target inhibitor.
Journal: Bioorganic & medicinal chemistry
Published: September 05, 2025
Orthosteric-allosteric dual inhibitors of PI5P4Kγ with potent antitumor activity in non-small cell lung cancer.
Journal: Journal of advanced research
Published: June 05, 2025
Orthosteric-allosteric dual inhibitors of PI5P4Kγ with potent antitumor activity in non-small cell lung cancer.
Journal: Journal of advanced research
Published: June 05, 2025
Discovery of 3-(2-aminobenzo[d]thiazol-5-yl) benzamide derivatives as potent anticancer agents via ROR1 inhibition.
Journal: Bioorganic & medicinal chemistry
Published: August 12, 2024
Design and synthesis of novel derivatives of bisepoxylignans as potent anti-inflammatory agents involves the modulation of the M1/M2 microglia phenotype via TLR4/NF-κB signaling pathway.
Journal: European journal of medicinal chemistry
Published: May 25, 2024
Synthesis and antitumor activities of novel 3-(6-aminopyridin-3-yl)benzamide derivatives: Inducing cell cycle arrest and apoptosis via AURKB transcription inhibition.
Journal: Bioorganic chemistry
Published: April 07, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026